Inventor · disambiguated record
Ian Henderson
Also filed as: HENDERSON IAN · HENDERSON IAN M · HENDERSON IAN MICHAEL
15 granted patents·16 pending applications·307 citations·filing 1995–2023
94Inventor score
Files withPHARMACOPEIA INC8PHARMACOPEIA DRUG DISCOVERY4LIGAND PHARM INC3BIOPHAGY INC2GILEAD PALO ALTO INC2
Top patents by PatentIndex Score
31 records- 0195US7723340B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2006·Granted May 25, 2010·46 cites·51 claims
- 0290US7253174B2N-heterocyclic inhibitors of TNF-α expressionPHARMACOPEIA INC·Filed 2006·Granted Aug 7, 2007·15 cites·8 claims
- 0388US5766963ACombination hydroxypropylamine libraryPHARMACOPEIA INC·Filed 1996·Granted Jun 16, 1998·73 cites·6 claims
- 0488US5618825ACombinatorial sulfonamide libraryPHARMACOPEIA INC·Filed 1995·Granted Apr 8, 1997·73 cites·10 claims
- 0587US7662819B2Pteridinone derivatives for use as stearoyl CoA desaturase inhibitorsGILEAD PALO ALTO INC·Filed 2007·Granted Feb 16, 2010·15 cites·17 claims
- 0687US7479495B2N-heterocyclic inhibitors of TNF-α expressionPHARMACOPEIA INC·Filed 2005·Granted Jan 20, 2009·11 cites·32 claims
- 0786US6906067B2N-heterocyclic inhibitors of TNF-α expressionPHARMACEOPEIA INC·Filed 2001·Granted Jun 14, 2005·35 cites·20 claims
- 0885US8044040B2N-heterocyclic inhibitors of TNF-alpha expressionBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 25, 2011·6 cites·2 claims
- 0983US9993461B2Method for treating disorders associated with glomerular functionLIGAND PHARM INC·Filed 2017·Granted Jun 12, 2018·5 cites·11 claims
- 1082US7951803B28-heteroarylpurine MNK2 inhibitors for treating metabolic disordersPHARMACOPEIA LLC·Filed 2007·Granted May 31, 2011·10 cites·20 claims
- 1178US9662312B2Method for treating glomerulosclerosisLIGAND PHARM INC·Filed 2015·Granted May 30, 2017·3 cites·4 claims
- 1271US2023190701A1Compounds for Treating Tauopathies and Restless Leg Syndrome and Methods of Using and Screening for SameTHE US GOV AS REPRESENTED·Filed 2023·Application pending·0 cites
- 1368US2022031653A1Compounds for Treating Tauopathies and Restless Leg Syndrome and Methods of Using and Screening for SameUS GOV VETERANS AFFAIRS·Filed 2021·Application pending·0 cites
- 1467US11208371B2Compounds, compositions, and methods for use in treating autophagy-associated disordersBIOPHAGY INC·Filed 2019·Granted Dec 28, 2021·0 cites·32 claims
- 1562US11987564B2PTPRD inhibitors and uses thereofUS GOV VETERANS AFFAIRS·Filed 2022·Granted May 21, 2024·0 cites·16 claims
- 1660US2009312320A1Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereofSIGNAL PHARM LLC·Filed 2009·Application pending·0 cites
- 1759US2022073444A1Compounds, Compositions, and Methods for use in Treating Autophagy-Associated DisordersBIOPHAGY INC·Filed 2021·Application pending·0 cites
- 1858US5756810AProcess of preparing 3-nitro benzoate compounds in lower alkanolPHARMACOPEIA INC·Filed 1995·Granted May 26, 1998·12 cites·4 claims
- 1954US2018344705A1Method for treating chronic inflammatory diseasesLIGAND PHARM INC·Filed 2018·Application pending·0 cites
- 2050US2014142149A1Oral formulations of diphenylsulfonamide endothelin and angiotensin ii receptor agonists to treat elevated blood pressure and diabetic nephropathyZHANG JINKUN·Filed 2012·Application pending·0 cites
- 2149US2003139435A1N-heterocyclic inhibitors of TNF-alpha expressionFiled 2002·Application pending·0 cites
- 2246US2011071130A12-aminobenzimidazoles for treating neurodegenerative diseasesPHARMACOPEIA INC·Filed 2007·Application pending·0 cites
- 2346US2008146536A12-Aminoimidazopyridines for treating neurodegenerative diseasesPHARMACOPEIA INC·Filed 2006·Application pending·0 cites
- 2444US2009005568A1Substituted 2-aminothiazoles for treating neurodegenerative diseasesPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 2543US2009023723A1Purinone derivatives for treating neurodegenerative diseasesPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 2642US2011230480A18-heteroarylpurine mnk2 inhibitors for treating metabolic disordersCOLE ANDREW G·Filed 2011·Application pending·0 cites
- 2742US2007225304A1Aminopurine derivatives for treating neurodegenerative diseasesPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 2842US2019194236A1Organometallic AntibioticsHENDERSON IAN MICHAEL·Filed 2017·Application pending·0 cites
- 2941US2008312215A1Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disordersPHARMACOPEIA DRUG DISCOVERY·Filed 2006·Application pending·0 cites
- 3039US2010113463A1PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
- 3134US5851494ASolid phase synthesis reaction vessel and method of using the samePHARMACOPEIA INC·Filed 1997·Granted Dec 22, 1998·3 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Ian Henderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →